JCR Pharmaceuticals Hits Day High with 7.88% Surge in Stock Price

JCR Pharmaceuticals Co., Ltd. has experienced a significant uptick in its stock performance, gaining 7.88% on April 17, 2026. The stock reached an intraday high of JPY 643.00, marking a notable moment in its trading activity. This performance stands in contrast to the Japan Nikkei 225, which declined by 1.75% on the same day. Over the past week, JCR Pharmaceuticals has shown a robust increase of 9.41%, although its one-month performance reflects a modest gain of 1.82%. In the longer term, the stock has generated a return of 43.59% over the past year, despite underperforming the broader market, which saw a return of 70.10% during the same period. The company's market capitalization is approximately JPY 93,244 million, categorizing it as a small-cap entity within the pharmaceuticals and biotechnology industry. However, it is important to note that JCR Pharmaceuticals has faced challenges, including negative EBITDA and a significant decline in profits over the past year. The stock's performance metrics indicate a complex financial landscape as it navigates its current market position.